BIA
PRCT icon

Biondo Investment Advisors’s Procept Biorobotics PRCT Stock Holding History

Biondo Investment Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.33M Buy
59,120
+38,845
+192% +$973K 0.16% 70
2026
Q1 		$507K Buy
20,275
+350
+2% +$9.86K 0.07% 73
2025
Q4 		$627K Sell
19,925
-102,510
-84% -$3.4M 0.08% 75
2025
Q3 		$4.37M Buy
122,435
+2,986
+2% +$136K 0.55% 42
2025
Q2 		$6.88M Buy
119,449
+2,535
+2% +$143K 0.91% 37
2025
Q1 		$6.81M Buy
116,914
+944
+0.8% +$64.5K 0.97% 38
2024
Q4 		$9.34M Buy
115,970
+13,260
+13% +$1.13M 1.29% 30
2024
Q3 		$8.23M Buy
+102,710
New +$7.3M 1.13% 36

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Biondo Investment Advisors's PRCT Position: Q2 2026 in Review

Biondo Investment Advisors increased its Procept Biorobotics (PRCT) stake by 192% in Q2 2026, buying an estimated $973K and bringing the position to 59,120 shares worth $1.33M. The position accounts for 0.16% of the portfolio, ranked #70.

Biondo Investment Advisors first reported a position in PRCT in Q3 2024 and has held it in 8 quarters since. The position peaked at $9.34M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Biondo Investment Advisors held 59,120 shares of Procept Biorobotics worth $1.33M as of Q2 2026.
  • Biondo Investment Advisors bought 38,845 Procept Biorobotics shares in Q2 2026, an estimated $973K.
  • Procept Biorobotics made up 0.16% of Biondo Investment Advisors's portfolio in Q2 2026, its #70 holding.
  • Biondo Investment Advisors first reported a position in Procept Biorobotics in Q3 2024 and has held it in 8 quarters since.
  • Biondo Investment Advisors's Procept Biorobotics position peaked at $9.34M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Biondo Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.